Nova Biomedical’s Educational Webinar Series Presents:
Preventing Intrapartum Foetal Hypoxia and Acidosis with POC Lactate

Tuesday, 20 June 2017    3 pm BST

Foetal lactate estimation has long been recognised as an alternative method of establishing the presence of foetal metabolic acidaemia. With recent updates to the NICE clinical guideline 190 (for intrapartum care for healthy women and babies), more obstetricians are using lactate foetal blood sampling (FBS) to determine intrapartum foetal hypoxia and acidosis. Lactate testing can be revolutionary in cases where pH FBS testing is inappropriate or the sample is inadequate or of a poor quality. Although routinely used in Sweden, France and Australia, UK obstetricians have been hesitant to adopt lactate point-of-care testing (POCT) without evidence-based practice. This webinar will cover the benefits of lactate POCT using FBS, how lactate FBS compares to pH in identifying intrapartum foetal distress, and an overview of a NHS trust study to determine the impact of lactate POCT on the detection of foetal hypoxia and acidosis during labour.


Learning Objectives

  1. Discuss the evolving practice of lactate testing with FBS.
  2. Learn how to identify hypoxia and acidosis during labour with lactate POCT.
  3. Understand how a busy NHS trust underwent a study of lactate and pH POCT and discuss its findings.
  4. Determine whether measuring fetal scalp lactate with a POC lactate meter can help identify foetal distress and the need for intervention.
  5. Assess whether your institution could benefit from lactate POCT for foetal patients.



Who should attend?

• POC practitioners • Biomedical scientists • Clinical chemists
• Neonatologists • Obstetricians
Featured Speaker



Clare Bailey, MSc, FIBMS
Lead Biomedical Scientist for POCT Barking, Havering and Redbridge University Hospitals

Having studied Marine Biology and Zoology at Bangor University in North Wales, she began training as Biomedical Scientist in Clinical Chemistry at Southend University Hospital; completing her Bsc and Msc in Biomedical Science at the University of Greenwich. She stayed here from 2004 – 2015, where she took on the role of Senior BMS in Point of Care Testing before becoming Lead Biomedical Scientist for Point of Care for Barking, Havering and Redbridge University Hospitals covering 95 clinical areas. Clare is passionate about Point of Care Testing and is a member of the QPoint EQAS Steering Group.


REGISTER HERE


View On-Demand Webinars